Penicillin v
Beepen-vk, Betapen-vk, Ledercillin, Pen-vee, Penapar-vk, Pfizerpen, Uticillin, V-cillin, Veetids (penicillin v) is a small molecule pharmaceutical. Penicillin v was first approved as V-cillin on 1982-01-01. It is used to treat bacillus anthracis, bacterial infections, diphtheria, gram-positive bacterial infections, and meningococcal meningitis amongst others in the USA.
Download report
Favorite
Searched
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
penicillin v potassium | ANDA | 2023-06-14 |
pfizerpen | ANDA | 2022-07-19 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
bacillus anthracis | NCBITaxon_1392 | D001408 | — |
bacterial infections | — | D001424 | A49 |
diphtheria | EFO_0005549 | D004165 | A36 |
gram-positive bacterial infections | — | D016908 | — |
meningococcal meningitis | EFO_1001040 | D008585 | A39.0 |
pasteurella infections | EFO_0007424 | D010326 | A28.0 |
pneumococcal infections | EFO_0000772 | D011008 | J13 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
44 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Syphilis | D013587 | EFO_0007504 | A53.9 | 1 | 2 | 2 | 5 | — | 9 |
Tonsillitis | D014069 | HP_0011110 | J03 | — | — | — | 2 | 1 | 3 |
Infections | D007239 | EFO_0000544 | — | — | 1 | 1 | — | 2 | |
Pharyngitis | D010612 | R07.0 | — | — | — | 1 | 1 | 2 | |
Bacterial meningitis | D016920 | EFO_1000831 | G00 | — | — | — | 1 | — | 1 |
Lyme disease | D008193 | A69.2 | — | — | — | 1 | — | 1 | |
Erythema chronicum migrans | D015787 | A26.0 | — | — | — | 1 | — | 1 | |
Communicable diseases | D003141 | — | — | — | 1 | — | 1 | ||
Staphylococcus aureus | D013211 | NCBITaxon_1280 | — | — | — | 1 | — | 1 | |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | — | 1 | — | 1 |
Show 5 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pneumonia | D011014 | EFO_0003106 | J18 | — | — | 2 | — | 1 | 3 |
Sepsis | D018805 | A41.9 | — | — | 2 | — | — | 2 | |
Yaws | D015001 | EFO_0007548 | A66 | — | — | 1 | — | — | 1 |
Treponemal infections | D014211 | EFO_1001217 | — | — | 1 | — | — | 1 | |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | 1 | — | — | 1 |
Microbial drug resistance | D004352 | — | — | 1 | — | — | 1 | ||
Endocarditis | D004696 | EFO_0000465 | I33 | — | — | 1 | — | — | 1 |
Bacterial infections | D001424 | A49 | — | — | 1 | — | — | 1 | |
Neonatal sepsis | D000071074 | HP_0040187 | — | — | 1 | — | — | 1 | |
Hiv | D006678 | O98.7 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Rheumatic heart disease | D012214 | EFO_1001161 | I09.9 | — | 2 | — | — | 1 | 3 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | — | — | — | 1 |
Psoriasis | D011565 | EFO_0000676 | L40 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | 3 | — | — | — | — | 3 | ||
Oxidative stress | D018384 | EFO_1001905 | 1 | — | — | — | — | 1 | |
Streptococcus agalactiae | D013292 | NCBITaxon_1311 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | — | 1 | 1 |
Neurosyphilis | D009494 | EFO_0007339 | A50.4 | — | — | — | — | 1 | 1 |
Peritonsillar abscess | D000039 | EFO_0007429 | J36 | — | — | — | — | 1 | 1 |
Chorea | D002819 | EFO_0004152 | G25.5 | — | — | — | — | 1 | 1 |
Streptococcal infections | D013290 | EFO_1001476 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | PENICILLIN V |
INN | phenoxymethylpenicillin |
Description | Phenoxymethylpenicillin is a penicillin compound having a 6beta-(phenoxyacetyl)amino side-chain. It is a penicillin allergen and a penicillin. It is a conjugate acid of a phenoxymethylpenicillin(1-). |
Classification | Small molecule |
Drug class | penicillins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O |
Identifiers
PDB | — |
CAS-ID | 87-08-1 |
RxCUI | 7984 |
ChEMBL ID | CHEMBL615 |
ChEBI ID | 27446 |
PubChem CID | 6869 |
DrugBank | DB00417 |
UNII ID | Z61I075U2W (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 4,175 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
38,172 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more